| Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open … A Wang-Gillam, CP Li, G Bodoky, A Dean, YS Shan, G Jameson, ... The Lancet 387 (10018), 545-557, 2016 | 1158 | 2016 |
| Natural products in anticancer therapy AB Da Rocha, RM Lopes, G Schwartsmann Current opinion in pharmacology 1 (4), 364-369, 2001 | 854 | 2001 |
| GlioVis data portal for visualization and analysis of brain tumor expression datasets RL Bowman, Q Wang, A Carro, RGW Verhaak, M Squatrito Neuro-oncology 19 (1), 139-141, 2017 | 663 | 2017 |
| Planning cancer control in Latin America and the Caribbean PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ... The lancet oncology 14 (5), 391-436, 2013 | 624 | 2013 |
| Anti-cancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds DRA Mans, AB Rocha, G Schwartsmann The oncologist 5 (3), 185-198, 2000 | 418 | 2000 |
| Marine organisms as a source of new anticancer agents G Schwartsmann, AB da Rocha, RGS Berlinck, J Jimeno The lancet oncology 2 (4), 221-225, 2001 | 401 | 2001 |
| Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy DB Cornelio, R Roesler, G Schwartsmann Annals of Oncology 18 (9), 1457-1466, 2007 | 279 | 2007 |
| Anticancer drug discovery and development throughout the world. G Schwartsmann, MJ Ratain, GM Cragg, JE Wong, N Saijo, DR Parkinson, ... Journal of clinical oncology: official journal of the American Society of …, 2002 | 238 | 2002 |
| A multicenter phase II study of XRP6258 administered as a 1-h iv infusion every 3 weeks in taxane-resistant metastatic breast cancer patients X Pivot, P Koralewski, JL Hidalgo, A Chan, A Goncalves, ... Annals of oncology 19 (9), 1547-1552, 2008 | 229 | 2008 |
| Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas? AB Da Rocha, DRA Mans, A Regner, G Schwartsmann The oncologist 7 (1), 17-33, 2002 | 202 | 2002 |
| Breast cancer in South America: challenges to improve early detection and medical management of a public health problem. G Schwartsmann Journal of Clinical Oncology: Official Journal of the American Society of …, 2001 | 180 | 2001 |
| Overview of breast health care guidelines for countries with limited resources BO Anderson, S Braun, RW Carlson, JR Gralow, MD Lagios, C Lehman, ... The breast journal 9, S42-S50, 2003 | 164 | 2003 |
| Essential drugs for cancer therapy: a World Health Organization consultation K Sikora, S Advani, V Koroltchouk, I Magrath, L Levy, H Pinedo, ... Annals of Oncology 10 (4), 385-390, 1999 | 156 | 1999 |
| Marine organisms and other novel natural sources of new cancer drugs G Schwartsmann Annals of Oncology 11, 235-244, 2000 | 153 | 2000 |
| Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas CO Da Fonseca, G Schwartsmann, J Fischer, J Nagel, D Futuro, ... Surgical neurology 70 (3), 259-266, 2008 | 149 | 2008 |
| Evidence for an association of human papillomavirus infection and colorectal cancer DC Damin, MB Caetano, MA Rosito, G Schwartsmann, AS Damin, ... European Journal of Surgical Oncology (EJSO) 33 (5), 569-574, 2007 | 146 | 2007 |
| Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders R Roesler, JAP Henriques, G Schwartsmann CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2006 | 145 | 2006 |
| Anticancer, antichemotactic and antimicrobial activities of marine sponges collected off the coast of Santa Catarina, southern Brazil NR Monks, C Lerner, AT Henriques, FM Farias, EES Schapoval, ... Journal of Experimental Marine Biology and Ecology 281 (1-2), 1-12, 2002 | 143 | 2002 |
| EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models HR Hendriks, PE Pizao, DP Berger, KL Kooistra, MC Bibby, E Boven, ... European Journal of Cancer 29 (6), 897-906, 1993 | 142 | 1993 |
| Sequence-dependent growth inhibition and DNA damage formation by the irinotecan–5-fluorouracil combination in human colon carcinoma cell lines DRA Mans, I Grivicich, GJ Peters, G Schwartsmann European Journal of Cancer 35 (13), 1851-1861, 1999 | 132 | 1999 |
